Zhejiang Taimei Medical Technology Co., Ltd.

SEHK:2576 Stock Report

Market Cap: HK$3.4b

Zhejiang Taimei Medical Technology Past Earnings Performance

Past criteria checks 0/6

Zhejiang Taimei Medical Technology has been growing earnings at an average annual rate of 5.5%, while the Healthcare Services industry saw earnings growing at 15.2% annually. Revenues have been growing at an average rate of 3.8% per year.

Key information

5.5%

Earnings growth rate

17.1%

EPS growth rate

Healthcare Services Industry Growth22.3%
Revenue growth rate3.8%
Return on equity-36.0%
Net Margin-62.3%
Last Earnings Update31 Mar 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Zhejiang Taimei Medical Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:2576 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 24576-359493144
31 Dec 23573-347427169
31 Dec 22549-413478208
31 Dec 21466-480450191
31 Dec 20303-524518109
31 Dec 19187-38940384
31 Dec 1860-18314641

Quality Earnings: 2576 is currently unprofitable.

Growing Profit Margin: 2576 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2576 is unprofitable, but has reduced losses over the past 5 years at a rate of 5.5% per year.

Accelerating Growth: Unable to compare 2576's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2576 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (11.9%).


Return on Equity

High ROE: 2576 has a negative Return on Equity (-36.01%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies